First Majestic Silver Corp. (TSX:AG)

CTI BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,243	2,385	2,333	2,994	3,611	3,786
Market Cap Growth	103.94%	2.22%	-22.09%	-17.07%	-4.64%	16.06%
Enterprise Value	5,572	2,405	2,416	3,124	3,620	3,658
Last Close Price	10.82	7.89	8.09	11.18	13.91	16.87
PE Ratio	-	-	-	-	-	128.71
Forward PE	33.68	17.04	37.81	28.92	28.30	27.35
PS Ratio	5.22	2.96	3.08	3.54	4.89	8.17
PB Ratio	1.29	1.23	1.30	1.57	2.02	3.50
P/TBV Ratio	1.51	1.23	1.30	1.57	2.02	3.50
P/FCF Ratio	67.46	44.98	-	-	-	-
P/OCF Ratio	18.70	10.91	31.76	116.52	41.52	37.28
PEG Ratio	-	0.08	0.08	0.08	0.08	0.08
EV/Sales Ratio	5.55	2.98	3.19	3.70	4.90	7.89
EV/EBITDA Ratio	16.49	13.05	-	27.53	17.61	25.90
EV/EBIT Ratio	58.55	301.84	-	-	61.14	52.04
EV/FCF Ratio	71.68	45.36	-	-	-	-
Debt / Equity Ratio	0.08	0.18	0.19	0.18	0.16	0.20
Debt / EBITDA Ratio	1.00	1.69	-	2.70	1.31	1.52
Debt / FCF Ratio	4.34	6.43	-	-	-	-
Asset Turnover	0.23	0.28	0.28	0.30	0.35	0.32
Inventory Turnover	5.35	5.84	6.73	7.72	8.12	6.94
Quick Ratio	2.65	2.07	1.97	1.36	1.84	3.16
Current Ratio	3.19	2.56	2.57	2.21	2.30	3.50
Return on Equity (ROE)	-3.93%	-7.52%	-9.76%	-8.10%	-0.43%	3.05%
Return on Assets (ROA)	1.38%	0.18%	-4.24%	-1.52%	1.74%	3.06%
Return on Capital (ROIC)	1.77%	0.22%	-5.30%	-1.96%	2.20%	3.70%
Return on Capital Employed (ROCE)	1.70%	0.30%	-	-	2.40%	4.90%
Earnings Yield	-2.36%	-6.15%	-7.65%	-5.17%	-0.17%	0.78%
FCF Yield	1.48%	2.22%	-5.12%	-8.98%	-4.21%	-1.08%
Dividend Yield	0.24%	0.34%	0.33%	0.29%	0.21%	-
Buyback Yield / Dilution	-18.01%	-4.68%	-7.30%	-7.51%	-13.37%	-7.07%
Total Shareholder Return	-17.77%	-4.34%	-6.97%	-7.22%	-13.16%	-7.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.